JANX vs WTW · rev $10.3M vs P/E 15, rev $4.88B
Janux Therapeutics Inc (JANX) versus Willis Towers Watson PLC (WTW) — a side-by-side from cached financials, not a winner call.
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
Willis Towers Watson PLC (WTW) is a insurance brokers company listed on NASDAQ.
Latest reported JANX revenue for 2026-06-30 was $10.3M. Net income was -$22.0M. JANX currently screens at market cap $1.49B.
Latest reported WTW revenue for 2026-06-30 was $4.88B. Net income was $526.0M. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
JANX currently screens at market cap $1.49B. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
Not investment advice. Open the JANX and WTW stock pages for the full models.
Not investment advice.